Consumption of Nuts and Seeds and Telomere Length in 5,582 Men and Women of the National Health and Nutrition Examination Survey (NHANES)

Telomeres » Institutional Study » Consumption of Nuts and Seeds and Telomere Length in 5,582 Men and Women of the National Health and Nutrition Examination Survey (NHANES)

March 15, 2017 | Amy | 2 Comments

Peer-Reviewed Scientific Journal:
Journal of Nutrition, Health and Aging

Size of study:
5,582 healthy adults from the National Health and Nutrition Examination Survey (NHANES)

Summary
Consumption of nuts and seeds accounts for meaningful decreases in cellular aging. Nuts and seeds intake was positively and linearly associated with telomere length such that adults of the same age had more than 1.5 years of reduced cell aging if they consumed 5% of their total energy from nuts and seeds.

Link to study

SEE THE FULL STUDY

2 comments on “Consumption of Nuts and Seeds and Telomere Length in 5,582 Men and Women of the National Health and Nutrition Examination Survey (NHANES)”

Rev. Nagi says:

February 19, 2018 at 3:09 pm

Absolutely fascinating! Thank you!

Reply
jack says:

July 5, 2018 at 5:10 pm

this is so informative

Reply

Leave a Reply Cancel reply

The TeloYears test is not intended for screening, diagnosing, treating or preventing diseases or medical conditions. The TeloYears genetic test may indicate the possibility of identifying a rare telomere syndrome associated with extremely shorter or longer average telomere length (ATL). In these rare cases, further testing and consultation with a doctor to rule in or rule out a telomere syndrome is recommended. The test is available for individuals between the ages of 20 to 80 within the United States, except for the states of Maryland and New York. The information provided by the TeloYears test should not be used to replace medically appropriate screening tests recommended based upon actual age or other risk factors, nor should the information be used to make decisions about diagnosis or treatment of diseases or medical conditions. The Telomere Diagnostics lab is regulated under the Clinical Laboratory improvement Amendments of 1988 (CLIA) as qualified to perform high complexity clinical testing. The performance characteristics of this test were determined by Telomere Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration.